The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Avelox 400 mg/250 ml solution for infusion

400 mg /250 millilitre(s) Solution for infusion

Bayer LimitedPA1410/027/003

Main Information

Trade NameAvelox 400 mg/250 ml solution for infusion
Active SubstancesMoxifloxacin hydrochloride
Strength400 mg /250 millilitre(s)
Dosage FormSolution for infusion
Licence HolderBayer Limited
Licence NumberPA1410/027/003

Group Information

ATC CodeJ01MA Fluoroquinolones
J01MA14 moxifloxacin


Licence Issued04/04/2003
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back